Sodium aspirin
This article was originally published in The Tan Sheet
Executive Summary
FDA denies request by Pharmacontrol to include sodium aspirin in the internal analgesics monograph as a subset of aspirin or as a separate ingredient. In a June 4 letter, FDA stated that "aspirin and sodium aspirin are chemically related but are not identical," and asked the firm to submit information on the marketing history of sodium aspirin in other countries and on sodium aspirin's inclusion in any pharmacopeia. Pharmacontrol has been developing soluble sodium aspirin for nearly a decade.You may also be interested in...
People In Brief
In Brief
Supplement GMP Warning Letters Make Modest Debut In 2010
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: